Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib

Regen Ther. 2020 Jan 14:14:40-42. doi: 10.1016/j.reth.2019.11.003. eCollection 2020 Jun.

Authors

Hao Zhang^{1

2

1

3}, Yongxian Hu^{1

2

1

3}, Alex H Chang^{2

1

3}, He Huang^{1

3}

Affiliations

¹ Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
² Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
³ Institute of Hematology, Zhejiang University& Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China.

No abstract available